yjbI Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
yjbI antibody; b4038 antibody; JW3998 antibody; Putative protein YjbI antibody
Target Names
yjbI
Uniprot No.

Q&A

What is YjbI and what is its primary role in bacterial physiology?

YjbI is a group II truncated haemoglobin from Bacillus subtilis that functions as an antioxidant protein with a unique protein hydroperoxide peroxidase-like activity. This protein prevents oxidative aggregation of cell-surface proteins by removing hydroperoxide groups from oxidized proteins, thereby protecting bacteria from oxidative stress-mediated damage . The importance of YjbI becomes particularly evident in biofilm formation, where it protects the biofilm matrix protein TasA from oxidative aggregation, which is crucial for maintaining biofilm water repellence .

Unlike conventional antioxidant systems that operate intracellularly, YjbI primarily functions at the cell surface or within the biofilm matrix, providing protection to extracellular proteins that would otherwise be vulnerable to reactive oxygen species (ROS) . Disruption of the yjbI gene significantly increases bacterial sensitivity to oxidative stress, with yjbI-deficient mutants showing approximately 100 times higher sensitivity to hypochlorous acid compared to wild-type strains .

How does YjbI's structure relate to its function as a protein hydroperoxide peroxidase?

The X-ray crystal structure of B. subtilis YjbI (PDB ID: 1UX8) reveals a critical structural feature that enables its unique function: a 55 Ų surface opening that allows direct access of bulk solvent and large molecules to the haem active site . This structural characteristic distinguishes YjbI from other haem proteins like hemoglobin and myoglobin, which can only react with small peptide-sized hydroperoxides but not with large protein hydroperoxides such as bovine serum albumin hydroperoxide (BSA-OOH) .

The haem group is essential for YjbI's peroxidase-like activity, and specific amino acid residues surrounding the haem play crucial roles in the catalytic mechanism. Particularly, Tyr63 near the haem has been identified as critical for activity through site-directed mutagenesis studies. Replacement of Tyr63 with phenylalanine results in the loss of protein peroxidase-like activity, and the mutant gene fails to rescue biofilm water repellency and resistance to oxidative stress in the yjbI-deficient strain .

Additionally, electron donation is required for the protein hydroperoxide peroxidase-like reaction by YjbI. In vitro studies have shown that reduction of BSA-OOH and TasA-OOH by YjbI proceeds without addition of external electron donors, suggesting that electrons needed for the reaction may be provided from amino acid residues of YjbI itself, most likely tyrosine residues .

What are the recommended approaches for producing and purifying anti-YjbI antibodies?

Production of high-quality anti-YjbI antibodies requires careful attention to antigen preparation, immunization protocols, and purification strategies:

  • Antigen Preparation:

    • Express recombinant YjbI in E. coli BL21(DE3) using an expression vector containing the yjbI gene.

    • Induce with moderate concentrations of isopropyl β-d-1-thiogalactopyranoside (25 μM) for extended periods (10 hours) to optimize protein expression .

    • Purify using a multi-step approach involving ammonium sulfate fractionation (30-60% saturation), size exclusion chromatography (Sephacryl S-100), and ion exchange chromatography (DEAE-650M) .

  • Immunization Protocol:

    • Immunize rabbits with purified YjbI mixed with complete Freund's adjuvant.

    • Follow with multiple boosting injections (typically five, one week apart) to enhance antibody production and affinity .

    • This approach has been successfully used to generate anti-YjbI antisera with high specificity and sensitivity for various applications including western blotting and immunofluorescence .

  • Validation Strategies:

    • Test specificity against wild-type and yjbI-deficient B. subtilis strains to confirm antibody specificity.

    • Perform western blotting, immunoprecipitation, and immunofluorescence microscopy to validate antibody functionality across different applications.

    • Include pre-adsorption controls to demonstrate that pre-incubation with purified YjbI blocks antibody binding, confirming specificity.

How can researchers optimize immunolabeling protocols to detect YjbI in bacterial biofilms?

Detecting YjbI in biofilms presents unique challenges due to the complex architecture and heterogeneity of biofilm matrices. Optimized protocols should consider:

  • Fixation and Permeabilization:

    • Choose fixation methods that preserve biofilm structure while maintaining YjbI antigenicity (e.g., mild paraformaldehyde fixation).

    • For thick biofilms, consider cryosectioning to improve antibody penetration.

    • Optimize permeabilization conditions to allow antibody access while minimizing disruption of YjbI localization.

  • Antibody Incubation:

    • Use prolonged blocking steps (1-2 hours) with appropriate blockers (e.g., BSA, serum) to reduce non-specific binding.

    • Extend antibody incubation times (overnight at 4°C) to ensure penetration into dense biofilm structures.

    • Titrate antibody concentrations to determine optimal working dilution that maximizes specific signal while minimizing background .

  • Detection Systems:

    • For fluorescence microscopy, select fluorophores with spectral properties distinct from biofilm autofluorescence.

    • Include counterstains to visualize biofilm architecture (e.g., DAPI for cells, lectins for exopolysaccharides).

    • Use confocal microscopy for three-dimensional visualization of YjbI distribution throughout the biofilm depth.

  • Essential Controls:

    • Include yjbI-deficient biofilms as negative controls.

    • Use pre-immune serum controls to assess background.

    • Perform peptide competition controls to verify signal specificity.

    • Apply protease treatment to intact biofilms as an additional control, which should eliminate surface-exposed YjbI signals as demonstrated in previous studies .

How can researchers use anti-YjbI antibodies to study the protein's role in oxidative stress protection?

Anti-YjbI antibodies can be employed in several sophisticated experimental approaches to investigate YjbI's role in protecting bacteria from oxidative stress:

  • Functional Inhibition Studies:

    • Apply anti-YjbI antibodies to intact cells to selectively block YjbI function.

    • Previous research has demonstrated that treatment of wild-type B. subtilis cells with anti-YjbI antiserum before cultivation impaired colony biofilm formation and caused significant loss of surface repellence, phenocopying the effects seen in yjbI-deficient mutants .

    • This approach allows for temporal control of YjbI inhibition without genetic manipulation.

  • Cellular Localization:

    • Western blotting analysis of soluble and insoluble fractions from B. subtilis pellicles has shown that YjbI is detected primarily in the insoluble fraction .

    • Protease treatment of intact B. subtilis pellicles almost completely eliminates immunoreactive YjbI, confirming its exposure on the cell surface .

    • These findings support the hypothesis that YjbI functions primarily as an extracellular protein protecting surface-exposed components from oxidative damage.

  • Correlation with Oxidative Stress Conditions:

    • Monitor changes in YjbI expression and localization under various oxidative stress conditions using quantitative western blotting and immunofluorescence.

    • Compare wild-type responses to those of strains with modified YjbI (e.g., the Tyr63Phe mutant) to understand structure-function relationships.

    • Track the co-localization of YjbI with potential substrate proteins during oxidative stress exposure.

What are the key differences between YjbI and other haem proteins that researchers should consider when designing experiments?

When designing experiments involving YjbI and developing antibodies against it, researchers should consider several critical differences between YjbI and other haem proteins:

  • Functional Differences:

    • YjbI has a unique protein hydroperoxide peroxidase-like activity absent in hemoglobin and myoglobin.

    • While hemoglobin and myoglobin promote oxidative BSA aggregation/fragmentation, YjbI suppresses it .

    • These functional differences affect how control experiments should be designed when studying YjbI activity.

  • Substrate Specificity:

    • Hemoglobin and myoglobin can react with small peptide-sized hydroperoxides but not with large protein hydroperoxides such as BSA-OOH, whereas YjbI effectively reduces hydroperoxides in large proteins .

    • This difference in substrate specificity is likely due to structural differences that allow YjbI to accommodate larger substrates.

  • Reaction with Oxidants:

    • When coexisting with an oxidant, haem proteins like hemoglobin and myoglobin generally accelerate radical reactions.

    • In contrast, YjbI counteracts oxidative damage through its ability to remove hydroperoxide groups from proteins .

    • This fundamental difference in behavior with oxidants must be considered when designing oxidative stress experiments.

  • Localization:

    • Unlike many other haem proteins, YjbI localizes to the cell surface or biofilm matrix despite lacking an apparent targeting signal sequence .

    • This unusual localization affects experimental approaches for studying YjbI in its native context and may require specialized techniques for sample preparation.

How can researchers differentiate between specific and non-specific binding when using anti-YjbI antibodies?

Distinguishing specific from non-specific binding is crucial for accurate data interpretation when using anti-YjbI antibodies. Researchers should implement multiple validation strategies:

  • Genetic Controls:

    • Compare signals in wild-type versus yjbI-deficient B. subtilis strains.

    • Specific binding should be absent or significantly reduced in knockout samples, providing the most definitive control for antibody specificity .

  • Peptide Competition Assays:

    • Pre-incubate the antibody with purified YjbI protein before application to samples.

    • Specific signals should be reduced or eliminated in a concentration-dependent manner.

    • Non-specific signals will remain largely unchanged, allowing their identification.

  • Signal Characteristics Analysis:

    • In western blots, specific binding typically shows a single band of the expected molecular weight (~13 kDa for YjbI).

    • In immunofluorescence, specific binding should show consistent localization patterns that align with known YjbI biology (cell surface or biofilm matrix localization) .

    • Signal intensity should correlate with expected YjbI expression levels under different conditions.

  • Cross-validation with Multiple Techniques:

    • Confirm findings using different detection methods (western blotting, immunofluorescence, ELISA).

    • Consistency across techniques strengthens confidence in specific binding.

    • Consider orthogonal approaches such as RNA expression analysis to correlate protein detection with gene expression.

What experimental contradictions might researchers encounter when studying YjbI and how should they be interpreted?

Several apparent contradictions may emerge in YjbI research that require careful interpretation:

How can site-directed mutagenesis be combined with antibody approaches to study YjbI mechanism?

Combining site-directed mutagenesis with antibody-based detection provides powerful insights into YjbI's structure-function relationships:

  • Critical Residue Identification:

    • Previous research identified Tyr63 as crucial for YjbI's protein peroxidase-like activity through site-directed mutagenesis .

    • The Tyr63Phe mutant lost peroxidase-like activity and failed to rescue biofilm water repellency and oxidative stress resistance in yjbI-deficient strains .

    • Additional mutagenesis of other tyrosine residues or residues near the haem could further elucidate the catalytic mechanism.

  • Experimental Design Strategy:

    • Generate a panel of YjbI variants with mutations at key residues (particularly tyrosines that may serve as electron donors).

    • Express these variants in a yjbI-deficient background.

    • Use anti-YjbI antibodies to:

      • Confirm equivalent expression levels across mutants

      • Determine whether mutations affect protein localization

      • Assess impacts on protein stability and turnover rates

  • Structure-Function Analysis:

    • Combine immunodetection with functional assays measuring:

      • Protein hydroperoxide reduction capacity

      • Protection against oxidative aggregation

      • Biofilm formation and water repellency

    • Correlate structural changes (assessed by antibody epitope accessibility) with functional outcomes.

  • Epitope Mapping:

    • Determine whether mutations affect antibody binding, which can provide insights into protein conformation.

    • If mutations in specific regions eliminate antibody recognition, this suggests conformational changes that may relate to function.

    • Consider developing a panel of antibodies targeting different epitopes to create a more comprehensive structural analysis toolkit.

What methodological approaches can researchers use to study YjbI interactions with other proteins?

Understanding YjbI's interactions with other proteins, particularly its substrates, requires sophisticated methodological approaches:

  • Co-immunoprecipitation with Anti-YjbI Antibodies:

    • Use anti-YjbI antibodies to isolate YjbI and its interacting partners from B. subtilis biofilms or cell lysates.

    • Analyze co-precipitated proteins by mass spectrometry to identify potential substrates and interaction partners.

    • Compare interactomes under normal versus oxidative stress conditions to identify stress-specific interactions.

  • In vitro Interaction Studies:

    • Previous research demonstrated YjbI's interaction with oxidized proteins like BSA-OOH and TasA-OOH .

    • Similar approaches can be applied to test interactions with other potential substrate proteins:

      • Prepare hydroperoxidized candidate proteins using the Fenton reaction or AAPH

      • Incubate with purified YjbI and measure hydroperoxide reduction

      • Monitor prevention of protein aggregation through SDS-PAGE and silver staining

  • Proximity Labeling Approaches:

    • Fusion of proximity labeling enzymes (e.g., APEX2, BioID) to YjbI can identify proteins in close proximity in vivo.

    • Combined with antibody-based purification, this approach can map the dynamic YjbI interactome under different conditions.

    • Time-resolved studies can capture transient interactions that might be missed by co-immunoprecipitation.

  • Cross-linking Mass Spectrometry:

    • Chemical cross-linking followed by immunoprecipitation with anti-YjbI antibodies and mass spectrometry analysis can identify direct protein-protein interactions.

    • This approach can map specific interaction interfaces between YjbI and its substrates or partners.

    • Different cross-linkers with varying spacer lengths can provide structural insights into interaction geometries.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.